Citigroup Inc Celldex Therapeutics, Inc. Transaction History

Citigroup Inc

$196 Billion
Q2 2025

A detailed history of Citigroup Inc transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 99,200 shares of CLDX stock, worth $2.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

99,200

Previous 130,688 24.09%

Holding current value

$2.36 Million

Previous $2.37 Million 14.89%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$15.13 - $21.65 $476,413 - $681,715	-31,488 Reduced 24.09%	99,200 $2.02 Million
Q1 2025 May 12, 2025	BUY	$18.15 - $27.6 $205,621 - $312,680	11,329 Added 9.49%	130,688 $2.37 Million
Q4 2024 Feb 12, 2025	BUY	$23.31 - $32.4 $1.6 Million - $2.22 Million	68,629 Added 135.28%	119,359 $3.02 Million
Q3 2024 Nov 12, 2024	BUY	$32.06 - $44.56 $816,407 - $1.13 Million	25,465 Added 100.79%	50,730 $1.72 Million
Q2 2024 Aug 12, 2024	SELL	$32.76 - $42.56 $5.1 Million - $6.63 Million	-155,715 Reduced 86.04%	25,265 $935,000
Q1 2024 May 10, 2024	BUY	$35.22 - $51.88 $4.18 Million - $6.15 Million	118,639 Added 190.31%	180,980 $7.6 Million
Q4 2023 Feb 09, 2024	SELL	$22.61 - $40.65 $158,586 - $285,119	-7,014 Reduced 10.11%	62,341 $2.47 Million
Q3 2023 Nov 09, 2023	SELL	$25.45 - $37.46 $37,640 - $55,403	-1,479 Reduced 2.09%	69,355 $1.91 Million
Q2 2023 Aug 10, 2023	SELL	$30.29 - $38.28 $1.43 Million - $1.8 Million	-47,071 Reduced 39.92%	70,834 $2.4 Million
Q1 2023 May 11, 2023	BUY	$34.78 - $47.43 $1.89 Million - $2.58 Million	54,408 Added 85.69%	117,905 $4.24 Million
Q4 2022 Feb 09, 2023	SELL	$27.78 - $45.38 $3.5 Million - $5.71 Million	-125,915 Reduced 66.48%	63,497 $2.83 Million
Q3 2022 Nov 10, 2022	BUY	$22.7 - $37.57 $765,784 - $1.27 Million	33,735 Added 21.67%	189,412 $5.32 Million
Q2 2022 Aug 10, 2022	BUY	$20.5 - $37.33 $1.89 Million - $3.44 Million	92,158 Added 145.09%	155,677 $4.2 Million
Q1 2022 May 12, 2022	SELL	$27.64 - $39.32 $1.53 Million - $2.18 Million	-55,529 Reduced 46.64%	63,519 $2.16 Million
Q4 2021 Feb 10, 2022	BUY	$35.68 - $56.27 $347,487 - $548,013	9,739 Added 8.91%	119,048 $4.6 Million
Q3 2021 Nov 10, 2021	BUY	$28.95 - $55.99 $3.16 Million - $6.12 Million	109,309 New	109,309 $5.9 Million

Others Institutions Holding CLDX

# of Institutions

197

Shares Held

68.2M

Call Options Held

208K

Put Options Held

238K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.11B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account